Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F73JQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,710
Award facts
- Contract value 100% obligated
- $11,710.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11.71K to supply Gemtesa 75 mg tablets (90-count units) with a firm fixed price contract type. The contract, awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999.999 billion through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a critical position in the federal medical supply chain, particularly serving military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The underlying IDC vehicle enables the company to supply medical commodities globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program (Generation V) contracts with multiple regional awards, which may involve additional contractor participation.
Quick answers
Who was awarded contract SPE2DR26F73JQ?
SPE2DR26F73JQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F73JQ worth?
The government has obligated $11,710 on SPE2DR26F73JQ.
Is contract SPE2DR26F73JQ an order under another contract?
Yes. SPE2DR26F73JQ is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73JQ competed?
The extent of competition for SPE2DR26F73JQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award